- Home
- NAUT vs SMLR Comparison
NAUT vs SMLR Comparison
Compare NAUT & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- SMLR
- Stock Information
- Founded
- NAUT 2016
- SMLR 2007
- Country
- NAUT United States
- SMLR United States
- Employees
- NAUT N/A
- SMLR N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NAUT Industrials
- SMLR Health Care
- Exchange
- NAUT Nasdaq
- SMLR Nasdaq
- Market Cap
- NAUT 284.7M
- SMLR 289.5M
- IPO Year
- NAUT N/A
- SMLR 2014
- Fundamental
- Price
- NAUT $2.38
- SMLR $66.43
- Analyst Decision
- NAUT Buy
- SMLR
- Analyst Count
- NAUT 2
- SMLR 0
- Target Price
- NAUT $4.50
- SMLR N/A
- AVG Volume (30 Days)
- NAUT 116.7K
- SMLR 760.2K
- Earning Date
- NAUT 10-29-2024
- SMLR 11-04-2024
- Dividend Yield
- NAUT N/A
- SMLR N/A
- EPS Growth
- NAUT N/A
- SMLR N/A
- EPS
- NAUT N/A
- SMLR 2.04
- Revenue
- NAUT N/A
- SMLR $58,938,000.00
- Revenue This Year
- NAUT N/A
- SMLR N/A
- Revenue Next Year
- NAUT N/A
- SMLR N/A
- P/E Ratio
- NAUT N/A
- SMLR $29.08
- Revenue Growth
- NAUT N/A
- SMLR N/A
- 52 Week Low
- NAUT $2.19
- SMLR $20.88
- 52 Week High
- NAUT $3.46
- SMLR $76.98
- Technical
- Relative Strength Index (RSI)
- NAUT 42.12
- SMLR 79.63
- Support Level
- NAUT $2.21
- SMLR $43.17
- Resistance Level
- NAUT $2.92
- SMLR $53.36
- Average True Range (ATR)
- NAUT 0.17
- SMLR 7.46
- MACD
- NAUT -0.02
- SMLR 1.95
- Stochastic Oscillator
- NAUT 24.01
- SMLR 77.91
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.